{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:26:06Z","timestamp":1770506766058,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1038\/bjc.2014.447","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T20:01:47Z","timestamp":1407268907000},"page":"1710-1717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes"],"prefix":"10.1038","volume":"111","author":[{"given":"K W","family":"Hagberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K A","family":"McGlynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V V","family":"Sahasrabuddhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Jick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"key":"BFbjc2014447_CR1","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/jnci\/88.20.1472","volume":"88","author":"HO Adami","year":"1996","unstructured":"Adami HO, Chow WH, Nyr\u00e9n O, Berne C, Linet MS, Ekbom A, Wolk A, McLaughlin JK, Fraumeni JF Jr (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88: 1472\u20131477.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"BFbjc2014447_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","volume":"29","author":"SL Bowker","year":"2006","unstructured":"Bowker SL, Majumdar SR, Veugelers P, Johnson JA (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29 (2): 254\u2013258.","journal-title":"Diabetes Care"},{"issue":"4","key":"BFbjc2014447_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/gutjnl-2011-301708","volume":"62","author":"HP Chen","year":"2013","unstructured":"Chen HP, Shieh J, Chang CC, Chen TT, Lin JT, Wu MS, Lin JH, Wu CY (2013) Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. Gut 62 (4): 606\u2013615.","journal-title":"Gut"},{"issue":"11","key":"BFbjc2014447_CR4","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","volume":"3","author":"A Decensi","year":"2010","unstructured":"Decensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S (2010) Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila) 3 (11): 1451\u20131461.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"BFbjc2014447_CR5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1478-3231.2010.02223.x","volume":"30","author":"V Donadon","year":"2010","unstructured":"Donadon V, Balbi M, Mas MD, Casarin P, Zanette G (2010) Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver Int 30 (5): 750\u2013758.","journal-title":"Liver Int"},{"key":"BFbjc2014447_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","volume":"4","author":"HB El-Serag","year":"2006","unstructured":"El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4: 369\u2013380.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"BFbjc2014447_CR7","doi-asserted-by":"publisher","first-page":"e71583","DOI":"10.1371\/journal.pone.0071583","volume":"8","author":"M Franciosi","year":"2013","unstructured":"Franciosi M, Lucisano G, Lapice E, Strippoli GF, Pallegrini F, Nicolucci A (2013) Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. PLoS One 8 (8): e71583.","journal-title":"PLoS One"},{"key":"BFbjc2014447_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1749-6632.2011.06285.x","volume":"1243","author":"EJ Gallagher","year":"2011","unstructured":"Gallagher EJ, LeRoith D (2011) Diabetes, cancer, and metformin: connections of metabolism and cell proliferation. Ann N Y Acad Sci 1243: 54\u201368.","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"BFbjc2014447_CR9","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/cncr.24982","volume":"116","author":"MM Hassan","year":"2010","unstructured":"Hassan MM, Curley SA, Li D, Kaseb A, Davila M, Abdalla EK, Javel M, Moghazy DM, Lozano RD, Abbruzzese JL, Vauthey JN (2010) Association of diabetes duration and diabetes treatment with risk of hepatocellular carcinoma. Cancer 116 (8): 1938\u20131943.","journal-title":"Cancer"},{"key":"BFbjc2014447_CR10","unstructured":"International Agency for Research on Cancer (2014) Cancer Incidence in Five Continents, Vol. X (electronic versions) Lyon \n                    http:\/\/ci5.iarc.fr\/\n                    \n                   last accessed on January 22."},{"key":"BFbjc2014447_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/bmj.302.6779.766","volume":"302","author":"H Jick","year":"1991","unstructured":"Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerized data resource in the United Kingdom. BMJ 302: 766\u2013768.","journal-title":"BMJ"},{"key":"BFbjc2014447_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0140-6736(97)80084-0","volume":"349","author":"H Jick","year":"1997","unstructured":"Jick H, Jick SS, Derby LE, Vasilakis C, Myers MW, Meier CR (1997) Calcium channel blockers and risk of cancer. Lancet 349: 525\u2013528.","journal-title":"Lancet"},{"key":"BFbjc2014447_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/pds.2630010607","volume":"1","author":"H Jick","year":"1992","unstructured":"Jick H, Terris BZ, Derby LE, Jick SS (1992) Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1: 347\u2013349.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"BFbjc2014447_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","volume":"23","author":"SS Jick","year":"2003","unstructured":"Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruig\u00f3mez A, Meier CR, Schlienger RG, Black C, Jick H (2003) Validity of the general practice research database. Pharmacotherapy 23: 686\u2013689.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"BFbjc2014447_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1478-3231.2009.02191.x","volume":"30","author":"T Kawaguchi","year":"2010","unstructured":"Kawaguchi T, Taniguchi E, Morita Y, Shirachi M, Tateishi I, Nagata E, Sata M (2010) Association of exogenous insulin or sulphonylurea treatment with increased incidence of hepatoma in patients with hepatitis C virus infection. Liver Int 30 (3): 479\u2013486.","journal-title":"Liver Int"},{"key":"BFbjc2014447_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/qjmed\/91.6.445","volume":"91","author":"DH Lawson","year":"1998","unstructured":"Lawson DH, Sherman V, Hollowell J for the Scientific and Ethical Advisory Group (1998) The General Practice Research Database. Q J Med 91: 445\u2013452.","journal-title":"Q J Med"},{"key":"BFbjc2014447_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2407-11-20","volume":"11","author":"M Lee","year":"2011","unstructured":"Lee M, Hsu C, Wahlqvist ML, Tsai NH, Chang YH, Huang YC (2011) Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer 11: 20.","journal-title":"BMC Cancer"},{"key":"BFbjc2014447_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cld.2011.03.006","volume":"15","author":"KA McGlynn","year":"2011","unstructured":"McGlynn KA, London WT (2011) The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 15: 223\u2013243.","journal-title":"Clin Liver Dis"},{"key":"BFbjc2014447_CR19","unstructured":"NICE (2014) Pathways, Managing type 2 diabetes. National Institute for Health and Care Excellence (NICE): United Kingdom \n                    http:\/\/pathways.nice.org.uk\/pathways\/diabetes#path=view%3A\/pathways\/diabetes\/managing-type-2-diabetes.xml&content=close\n                    \n                   last accessed on January 28."},{"issue":"8","key":"BFbjc2014447_CR20","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1210\/jc.2010-2415","volume":"96","author":"G Nkontchou","year":"2011","unstructured":"Nkontchou G, Cosson E, Aout M, Mahmoudi A, Bourcier V, Charif I, Ganne-Carie N, Grando-Lemarie V, Vicante E, Trinchet JC, Beaugrand M (2011) Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. J Clin Endocrinol Metab 96 (8): 2601\u20132608.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"BFbjc2014447_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.dsx.2007.11.002","volume":"2","author":"SA Oliveria","year":"2008","unstructured":"Oliveria SA, Koro CE, Yood MU, Sowell M (2008) Cancer incidence among patients treated with antidiabetic pharmacotherapy. Diabetes Metab Syndr: Clin Res Rev 2 (1): 47\u201357.","journal-title":"Diabetes Metab Syndr: Clin Res Rev"},{"issue":"1","key":"BFbjc2014447_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2337\/dc11-0857","volume":"35","author":"R Ruiter","year":"2012","unstructured":"Ruiter R, Visser L, van Herk-Sukel MPP, Coebergh JW, Haak HR, Geelhoed-Duij Vestin PH, Straus SM, Herings RM, Stricker BH (2012) Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study. Diabetes Care 35 (1): 119\u2013124.","journal-title":"Diabetes Care"},{"key":"BFbjc2014447_CR23","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ajg.2013.5","volume":"108","author":"S Singh","year":"2013","unstructured":"Singh S, Singh PP, Singh AG, Murad MH, Sanchez W (2013) Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis. Am J Gastroenterol 108: 881\u2013891.","journal-title":"Am J Gastroenterol"},{"key":"BFbjc2014447_CR24","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/ijc.26165","volume":"130","author":"C Wang","year":"2012","unstructured":"Wang C, Wang X, Gong G, Ben Q, Qui W, Chen Y, Li G, Wang L (2012) Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer 130: 1639\u20131648.","journal-title":"Int J Cancer"},{"key":"BFbjc2014447_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/00365521.2012.719926","volume":"48","author":"H Zhang","year":"2013","unstructured":"Zhang H, Gao C, Fang L, Zhao HC, Yao SK (2013) Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scand J Gastroenterol 48: 78\u201387.","journal-title":"Scand J Gastroenterol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2014447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014447","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:25:17Z","timestamp":1684416317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2014447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["BFbjc2014447"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2014.447","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]},"assertion":[{"value":"24 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}